They're all talking about HPV, or human papillomavirus. It's the most common sexually transmitted infection, but it's also ...

Stay up-to-date with the latest and best audio content from CBC Listen delivered to your inbox every two weeks.

Kennedy has in particular focused on Gardasil, the HPV vaccine. A lawyer by trade, he has helped facilitate hundreds of potential lawsuits aimed at pharmaceutical company Merck, which manufactures ...

Merck & Co.’s blockbuster vaccine Gardasil has had a roller-coaster ride in China. A post-Covid surge in demand for the cancer-preventing shot quickly deflated last year, to the point the US ...

Merck & Co. (MRK) stock lost over 9% yesterday on announcing a temporary shipment halt of its Gardasil vaccine to China. The pharmaceutical giant’s CEO mentioned this in the Q4 earnings call ...

Management expects mid-to-high single-digit growth in Merck's total business outside of GARDASIL China in 2025, supported by increasing momentum in new product launches such as WINREVAIR and ...

The drugmaker plans to temporarily pause shipments of its Gardasil vaccine to China at least through the ... For 2025 Merck expects adjusted earnings to range between $8.88 and $9.03 per share on ...

Merck is hoping that Gardasil's expanded approval for men ages 9 to 26 in China will eventually help boost uptake of the shot. "We believe China still represents a significant long-term ...

The drugmaker plans to temporarily pause shipments of its Gardasil vaccine to China at least ... adjusted earnings to range between $8.88 and $9.03 per share on $64.1 billion to $65.6 billion ...